SIR2_HUMAN - dbPTM
SIR2_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID SIR2_HUMAN
UniProt AC Q8IXJ6
Protein Name NAD-dependent protein deacetylase sirtuin-2
Gene Name SIRT2
Organism Homo sapiens (Human).
Sequence Length 389
Subcellular Localization Nucleus. Cytoplasm, perinuclear region. Cytoplasm. Cytoplasm, cytoskeleton. Cytoplasm, cytoskeleton, microtubule organizing center, centrosome. Cytoplasm, cytoskeleton, microtubule organizing center, centrosome, centriole. Cytoplasm, cytoskeleton, spindle
Protein Description NAD-dependent protein deacetylase, which deacetylates internal lysines on histone and alpha-tubulin as well as many other proteins such as key transcription factors. [PubMed: 24177535]
Protein Sequence MAEPDPSHPLETQAGKVQEAQDSDSDSEGGAAGGEADMDFLRNLFSQTLSLGSQKERLLDELTLEGVARYMQSERCRRVICLVGAGISTSAGIPDFRSPSTGLYDNLEKYHLPYPEAIFEISYFKKHPEPFFALAKELYPGQFKPTICHYFMRLLKDKGLLLRCYTQNIDTLERIAGLEQEDLVEAHGTFYTSHCVSASCRHEYPLSWMKEKIFSEVTPKCEDCQSLVKPDIVFFGESLPARFFSCMQSDFLKVDLLLVMGTSLQVQPFASLISKAPLSTPRLLINKEKAGQSDPFLGMIMGLGGGMDFDSKKAYRDVAWLGECDQGCLALAELLGWKKELEDLVRREHASIDAQSGAGVPNPSTSASPKKSPPPAKDEARTTEREKPQ
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
2Acetylation------MAEPDPSHP
------CCCCCCCCC
36.7119413330
18 (in isoform 2)Ubiquitination-43.7421890473
23PhosphorylationKVQEAQDSDSDSEGG
CCCCCCCCCCCCCCC
27.2530278072
25PhosphorylationQEAQDSDSDSEGGAA
CCCCCCCCCCCCCCC
47.1630278072
27PhosphorylationAQDSDSDSEGGAAGG
CCCCCCCCCCCCCCC
41.9326055452
35 (in isoform 3)Ubiquitination-40.3521890473
46PhosphorylationDFLRNLFSQTLSLGS
HHHHHHHHCHHCCCC
25.9724076635
48PhosphorylationLRNLFSQTLSLGSQK
HHHHHHCHHCCCCHH
19.6724076635
50PhosphorylationNLFSQTLSLGSQKER
HHHHCHHCCCCHHHH
33.7924076635
53PhosphorylationSQTLSLGSQKERLLD
HCHHCCCCHHHHHHH
43.2925307156
55 (in isoform 4)Ubiquitination-46.6421890473
55 (in isoform 1)Ubiquitination-46.6421890473
55UbiquitinationTLSLGSQKERLLDEL
HHCCCCHHHHHHHHH
46.642189047
100PhosphorylationIPDFRSPSTGLYDNL
CCCCCCCCCCCCCCH
36.0324076635
101PhosphorylationPDFRSPSTGLYDNLE
CCCCCCCCCCCCCHH
34.2929978859
104PhosphorylationRSPSTGLYDNLEKYH
CCCCCCCCCCHHHCC
12.2528796482
121 (in isoform 2)Ubiquitination-2.5521890473
126UbiquitinationFEISYFKKHPEPFFA
HHHHHHHHCCCCCHH
55.27-
138 (in isoform 3)Ubiquitination-6.5221890473
158 (in isoform 4)Ubiquitination-50.2821890473
158 (in isoform 1)Ubiquitination-50.2821890473
158UbiquitinationFMRLLKDKGLLLRCY
HHHHHHHCCHHHHHH
50.28-
189PhosphorylationDLVEAHGTFYTSHCV
HHHHHCCEEEEHHCC
12.0023898821
191PhosphorylationVEAHGTFYTSHCVSA
HHHCCEEEEHHCCCH
13.7323898821
192PhosphorylationEAHGTFYTSHCVSAS
HHCCEEEEHHCCCHH
14.0623898821
193PhosphorylationAHGTFYTSHCVSASC
HCCEEEEHHCCCHHH
11.9623898821
197PhosphorylationFYTSHCVSASCRHEY
EEEHHCCCHHHCCCC
21.6223898821
199PhosphorylationTSHCVSASCRHEYPL
EHHCCCHHHCCCCCC
12.2723898821
204PhosphorylationSASCRHEYPLSWMKE
CHHHCCCCCCHHHHH
11.8923898821
207PhosphorylationCRHEYPLSWMKEKIF
HCCCCCCHHHHHHHH
22.1823898821
212UbiquitinationPLSWMKEKIFSEVTP
CCHHHHHHHHHCCCC
43.46-
215PhosphorylationWMKEKIFSEVTPKCE
HHHHHHHHCCCCCCH
34.3326270265
218PhosphorylationEKIFSEVTPKCEDCQ
HHHHHCCCCCCHHHH
16.9926270265
226PhosphorylationPKCEDCQSLVKPDIV
CCCHHHHHHCCCCEE
41.2726270265
238PhosphorylationDIVFFGESLPARFFS
CEEEECCCCCHHHHH
39.7824719451
271PhosphorylationLQVQPFASLISKAPL
CCHHCCHHHHHCCCC
26.9824719451
274PhosphorylationQPFASLISKAPLSTP
HCCHHHHHCCCCCCC
28.23-
279PhosphorylationLISKAPLSTPRLLIN
HHHCCCCCCCEEECC
34.9929449344
280PhosphorylationISKAPLSTPRLLINK
HHCCCCCCCEEECCH
21.8029449344
287UbiquitinationTPRLLINKEKAGQSD
CCEEECCHHHCCCCC
54.31-
311PhosphorylationGGGMDFDSKKAYRDV
CCCCCCCCHHHHCCC
35.7330387612
316MethylationFDSKKAYRDVAWLGE
CCCHHHHCCCHHHCC
36.4724379893
316DimethylationFDSKKAYRDVAWLGE
CCCHHHHCCCHHHCC
36.47-
331PhosphorylationCDQGCLALAELLGWK
CHHHHHHHHHHHCCH
2.16-
338AcetylationLAELLGWKKELEDLV
HHHHHCCHHHHHHHH
34.27156103
339UbiquitinationAELLGWKKELEDLVR
HHHHCCHHHHHHHHH
62.11-
351PhosphorylationLVRREHASIDAQSGA
HHHHHHHCCCCCCCC
23.9422167270
356PhosphorylationHASIDAQSGAGVPNP
HHCCCCCCCCCCCCC
32.1222167270
364PhosphorylationGAGVPNPSTSASPKK
CCCCCCCCCCCCCCC
41.4529255136
365PhosphorylationAGVPNPSTSASPKKS
CCCCCCCCCCCCCCC
29.5730266825
366PhosphorylationGVPNPSTSASPKKSP
CCCCCCCCCCCCCCC
30.9623401153
368PhosphorylationPNPSTSASPKKSPPP
CCCCCCCCCCCCCCC
36.7029255136
372PhosphorylationTSASPKKSPPPAKDE
CCCCCCCCCCCCCCC
49.0927512957
382PhosphorylationPAKDEARTTEREKPQ
CCCCCCCCCCCCCCC
39.8026074081
383PhosphorylationAKDEARTTEREKPQ-
CCCCCCCCCCCCCC-
27.7326074081

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
101TPhosphorylationKinasePRKAA1Q13131
GPS
104YPhosphorylationKinaseSRCP12931
PSP
331SPhosphorylationKinaseCDK2P24941
PSP
368SPhosphorylationKinaseCDK1P06493
PSP
368SPhosphorylationKinaseCDK2P24941
Uniprot
368SPhosphorylationKinaseCDK5Q00535
Uniprot

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference
368SAcetylation

17488717
368SPhosphorylation

17488717
368SPhosphorylation

17488717
368SPhosphorylation

17488717

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of SIR2_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
PHB2_HUMANPHB2physical
17353931
GYS1_HUMANGYS1physical
17353931
RTN4_HUMANRTN4physical
17353931
K2C78_HUMANKRT78physical
17353931
SYSC_HUMANSARSphysical
17353931
DNJB8_HUMANDNAJB8physical
20159555
DNJB6_HUMANDNAJB6physical
20159555
H31_HUMANHIST1H3Aphysical
19801601
EP300_HUMANEP300physical
18995842
EP300_HUMANEP300physical
18722353
ING1_HUMANING1physical
14522900
TAT_HV1H2tatphysical
15719057
FOXO1_HUMANFOXO1physical
15220471
RUNX3_HUMANRUNX3physical
21511279
FZR1_HUMANFZR1physical
22014574
CDC20_HUMANCDC20physical
22014574
FOXO1_HUMANFOXO1physical
24419059
EP300_HUMANEP300physical
23934153
H31_HUMANHIST1H3Aphysical
19270680
RBGPR_HUMANRAB3GAP2physical
26186194
GPAT1_HUMANGPAMphysical
26186194
RB3GP_HUMANRAB3GAP1physical
26186194
SCFD2_HUMANSCFD2physical
26186194
SYSC_HUMANSARSphysical
26186194
FADS1_HUMANFADS1physical
26186194
LYRIC_HUMANMTDHphysical
26186194
DEGS1_HUMANDEGS1physical
26186194
ORC2_HUMANORC2physical
26186194
TPC12_HUMANTRAPPC12physical
26186194
VAMP7_HUMANVAMP7physical
26186194
TBA4A_HUMANTUBA4Aphysical
12620231
SKP2_HUMANSKP2physical
26942878
MDM2_HUMANMDM2physical
28196907
PA24A_HUMANPLA2G4Aphysical
26303530
SYSC_HUMANSARSphysical
28514442
SCFD2_HUMANSCFD2physical
28514442
RB3GP_HUMANRAB3GAP1physical
28514442
GPAT1_HUMANGPAMphysical
28514442
ORC2_HUMANORC2physical
28514442
LYRIC_HUMANMTDHphysical
28514442
FADS1_HUMANFADS1physical
28514442
RBGPR_HUMANRAB3GAP2physical
28514442
DEGS1_HUMANDEGS1physical
28514442
VAMP7_HUMANVAMP7physical
28514442
GDIR1_HUMANARHGDIAphysical
26719334

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of SIR2_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-23; SER-27 AND SER-368, AND MASS SPECTROMETRY.
Phosphorylation
ReferencePubMed
"Large-scale proteomics analysis of the human kinome.";
Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.;
Mol. Cell. Proteomics 8:1751-1764(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-372, AND MASSSPECTROMETRY.
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-23; SER-27 AND SER-368, AND MASS SPECTROMETRY.
"Phosphoproteome of resting human platelets.";
Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,Schuetz C., Walter U., Gambaryan S., Sickmann A.;
J. Proteome Res. 7:526-534(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-25 AND SER-27, AND MASSSPECTROMETRY.

TOP